Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 158

    1.

    Toward Efficient Trials in Colorectal Cancer: The ARCAD Clinical Trials Program.

    de Gramont A, Haller DG, Sargent DJ, Tabernero J, Matheson A, Schilsky RL.

    J Clin Oncol. 2009 Oct 19. [Epub ahead of print] No abstract available. PMID: 19841311 [PubMed - as supplied by publisher]Related articles

    2.

    Improved patient and regimen selection in locally advanced rectal cancer: who, how, and what next?

    Weiss J, Moghanaki D, Plastaras JP, Haller DG.

    Clin Colorectal Cancer. 2009 Oct;8(4):194-9.PMID: 19822509 [PubMed - in process]Related articles

    3.

    Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease.

    Damjanov N, Weiss J, Haller DG.

    Oncologist. 2009 Oct;14(10):963-9. Epub 2009 Oct 9.PMID: 19819916 [PubMed - in process]Related articles

    4.

    Medical Oncology: Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer.

    Teitelbaum UR, Haller DG.

    Nat Rev Clin Oncol. 2009 May;6(5):250-1.PMID: 19390547 [PubMed - indexed for MEDLINE]Related articles

    5.

    Accomplishments in gastrointestinal oncology in 2007: conclusion.

    de Gramont A, Haller DG.

    Gastrointest Cancer Res. 2008 May;2(3 Suppl):S57. No abstract available. PMID: 19352471 [PubMed - in process]Related articlesFree article

    6.

    Accomplishments in 2007 in the adjuvant treatment of colorectal cancer.

    de Gramont A, Haller DG.

    Gastrointest Cancer Res. 2008 May;2(3 Suppl):S2-6.PMID: 19352464 [PubMed - in process]Related articlesFree article

    7.

    Provisional clinical opinion.

    Haller DG, Cox JV.

    J Clin Oncol. 2009 Apr 20;27(12):1925. Epub 2009 Mar 13. No abstract available. PMID: 19286976 [PubMed - indexed for MEDLINE]Related articles

    8.

    Gastrointestinal stromal tumors and neuroendocrine tumors.

    Grande C, Haller DG.

    Semin Oncol Nurs. 2009 Feb;25(1):48-60. Review.PMID: 19217505 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical trials registration: will your study be publishable?

    Haller DG.

    J Clin Oncol. 2009 Jan 1;27(1):1. Epub 2008 Nov 24. No abstract available. PMID: 19029415 [PubMed - indexed for MEDLINE]Related articles

    10.

    Bevacizumab beyond progression: does this make sense?

    Ellis LM, Haller DG.

    J Clin Oncol. 2008 Nov 20;26(33):5313-5. Epub 2008 Oct 14. No abstract available. PMID: 18854567 [PubMed - indexed for MEDLINE]Related articles

    11.

    Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.

    Haller DG, Rothenberg ML, Wong AO, Koralewski PM, Miller WH Jr, Bodoky G, Habboubi N, Garay C, Olivatto LO.

    J Clin Oncol. 2008 Oct 1;26(28):4544-50.PMID: 18824706 [PubMed - indexed for MEDLINE]Related articles

    12.

    Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.

    Rosenthal DI, Catalano PJ, Haller DG, Landry JC, Sigurdson ER, Spitz FR, Benson AB 3rd.

    Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):108-13.PMID: 18722265 [PubMed - indexed for MEDLINE]Related articles

    13.

    Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

    O'Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz JF, Benedetti JK, André T, Haller DG, Sargent DJ.

    J Clin Oncol. 2008 May 10;26(14):2336-41.PMID: 18467725 [PubMed - indexed for MEDLINE]Related articles

    14.

    Potential regional differences for the tolerability profiles of fluoropyrimidines.

    Haller DG, Cassidy J, Clarke SJ, Cunningham D, Van Cutsem E, Hoff PM, Rothenberg ML, Saltz LB, Schmoll HJ, Allegra C, Bertino JR, Douillard JY, Gustavsson BG, Milano G, O'Connell M, Rustum Y, Tabernero J, Gilberg F, Sirzén F, Twelves C.

    J Clin Oncol. 2008 May 1;26(13):2118-23.PMID: 18445840 [PubMed - indexed for MEDLINE]Related articles

    15.

    New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference.

    Rosen LS, Bilchik AJ, Beart RW Jr, Benson AB 3rd, Chang KJ, Compton CC, Grothey A, Haller DG, Ko CY, Lynch PM, Nelson H, Stamos MJ, Turner RR, Willett CG.

    Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6853s-6s.PMID: 18006789 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Colorectal cancer treatment in the elderly: tailored therapy approaches.

    Avadhani AN, Haller DG.

    Gastrointest Cancer Res. 2007 Nov;1(6):254-5. No abstract available. PMID: 19262904 [PubMed - in process]Related articlesFree article

    17.

    Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.

    Saltz LB, Rosen LS, Marshall JL, Belt RJ, Hurwitz HI, Eckhardt SG, Bergsland EK, Haller DG, Lockhart AC, Rocha Lima CM, Huang X, DePrimo SE, Chow-Maneval E, Chao RC, Lenz HJ.

    J Clin Oncol. 2007 Oct 20;25(30):4793-9. Erratum in: J Clin Oncol. 2008 Jan 20;26(3):514. PMID: 17947727 [PubMed - indexed for MEDLINE]Related articles

    18.

    A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer.

    Sun W, Hewitt MR, Theobald MR, Hershock D, Haller DG.

    Cancer. 2007 Dec 15;110(12):2768-74.PMID: 17932893 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

    Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Kerr D, Green E, Wieand HS, Goldberg RM, de Gramont A; ACCENT Group.

    J Clin Oncol. 2007 Oct 10;25(29):4569-74. Epub 2007 Sep 17.PMID: 17876008 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.

    Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, Ajani JA, Kocha W, Minsky BD, Roth JA, Willett CG; Radiation Therapy Oncology Group; USA Intergroup.

    J Clin Oncol. 2007 Aug 20;25(24):3719-25.PMID: 17704421 [PubMed - indexed for MEDLINE]Related articles

    21.

    Metastatic PEComa arising from renal angiomyolipoma: MRI findings.

    El Jack AK, Tomaszewski JE, Haller DG, Siegelman ES.

    J Magn Reson Imaging. 2007 Jul;26(1):159-61.PMID: 17659554 [PubMed - indexed for MEDLINE]Related articles

    22.

    Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.

    Marshall JL, Haller DG, de Gramont A, Hochster HS, Lenz HJ, Ajani JA, Goldberg RM.

    Gastrointest Cancer Res. 2007 Jul;1(4):146-54.PMID: 19262703 [PubMed - in process]Related articlesFree article

    23.

    Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups.

    O'Dwyer PJ, Eckhardt SG, Haller DG, Tepper J, Ahnen D, Hamilton S, Benson AB 3rd, Rothenberg M, Petrelli N, Lenz HJ, Diasio R, DuBois R, Sargent D, Sloan J, Johnson CD, Comis RL, O'Connell MJ; Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups.

    J Clin Oncol. 2007 Jun 1;25(16):2313-21. Review.PMID: 17538178 [PubMed - indexed for MEDLINE]Related articles

    24.

    Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.

    Dolinsky CM, Mahmoud NN, Mick R, Sun W, Whittington RW, Solin LJ, Haller DG, Giantonio BJ, O'Dwyer PJ, Rosato EF, Fry RD, Metz JM.

    J Surg Oncol. 2007 Sep 1;96(3):207-12.PMID: 17443718 [PubMed - indexed for MEDLINE]Related articles

    25.

    Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.

    Schmoll HJ, Cartwright T, Tabernero J, Nowacki MP, Figer A, Maroun J, Price T, Lim R, Van Cutsem E, Park YS, McKendrick J, Topham C, Soler-Gonzalez G, de Braud F, Hill M, Sirzén F, Haller DG.

    J Clin Oncol. 2007 Jan 1;25(1):102-9.PMID: 17194911 [PubMed - indexed for MEDLINE]Related articles

    26.

    Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.

    Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB 3rd, Strumberg D, Yanagihara R, Yao JC, Phan AT, Ajani JA.

    Cancer. 2007 Jan 1;109(1):33-40.PMID: 17133415 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Improving resectability of hepatic colorectal metastases: expert consensus statement by Abdalla et al.

    Adams RB, Haller DG, Roh MS.

    Ann Surg Oncol. 2006 Oct;13(10):1281-3. Epub 2006 Sep 9. No abstract available. PMID: 16964448 [PubMed - indexed for MEDLINE]Related articles

    28.

    Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.

    Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB 3rd, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS.

    J Clin Oncol. 2006 Aug 1;24(22):3542-7.PMID: 16877719 [PubMed - indexed for MEDLINE]Related articles

    29.

    Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.

    Hochster HS, Haller DG, de Gramont A, Berlin JD, Philip PA, Moore MJ, Ajani JA.

    Cancer. 2006 Aug 15;107(4):676-85.PMID: 16847885 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.

    Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D.

    J Clin Oncol. 2006 Feb 1;24(4):663-7.PMID: 16446338 [PubMed - indexed for MEDLINE]Related articles

    31.

    JCO and the Public Trust.

    Haller DG.

    J Clin Oncol. 2006 Jan 20;24(3):323-4. Epub 2005 Dec 19. No abstract available. PMID: 16365171 [PubMed - indexed for MEDLINE]Related articles

    32.

    Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

    Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG.

    J Clin Oncol. 2005 Dec 1;23(34):8706-12.PMID: 16314630 [PubMed - indexed for MEDLINE]Related articles

    33.

    Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

    Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, Mayer RJ.

    J Clin Oncol. 2005 Dec 1;23(34):8671-8.PMID: 16314627 [PubMed - indexed for MEDLINE]Related articles

    34.

    Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

    Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A.

    J Clin Oncol. 2005 Dec 1;23(34):8664-70. Epub 2005 Oct 31.PMID: 16260700 [PubMed - indexed for MEDLINE]Related articles

    35.

    Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.

    Sun W, Lipsitz S, Catalano P, Mailliard JA, Haller DG; Eastern Cooperative Oncology Group.

    J Clin Oncol. 2005 Aug 1;23(22):4897-904.PMID: 16051944 [PubMed - indexed for MEDLINE]Related articles

    36.

    A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.

    Cohen SJ, Dobelbower R Jr, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG; Eastern Cooperative Oncology Group.

    Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1345-50.PMID: 16029791 [PubMed - indexed for MEDLINE]Related articles

    37.

    A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer.

    Veronese ML, Sun W, Giantonio B, Berlin J, Shults J, Davis L, Haller DG, O'Dwyer PJ.

    Br J Cancer. 2005 May 23;92(10):1846-9.PMID: 15870719 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Adjuvant therapy for colon cancer.

    Sun W, Haller DG.

    Curr Oncol Rep. 2005 May;7(3):181-5. Review.PMID: 15847708 [PubMed - indexed for MEDLINE]Related articles

    39.

    Outcome results of the 1996-1999 patterns of care survey of the national practice for patients receiving radiation therapy for carcinoma of the esophagus.

    Suntharalingam M, Moughan J, Coia LR, Krasna MJ, Kachnic L, Haller DG, Willet CG, John MJ, Minsky BD, Owen JB.

    J Clin Oncol. 2005 Apr 1;23(10):2325-31.PMID: 15800323 [PubMed - indexed for MEDLINE]Related articles

    40.

    Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.

    Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS.

    J Clin Oncol. 2005 Mar 20;23(9):1819-25.PMID: 15774775 [PubMed - indexed for MEDLINE]Related articles

    41.

    Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancers.

    Haller DG.

    Semin Oncol. 2004 Dec;31(6 Suppl 14):10-6. Review.PMID: 15726529 [PubMed - indexed for MEDLINE]Related articles

    42.

    Adjuvant therapy of colon cancer.

    Sun W, Haller DG.

    Semin Oncol. 2005 Feb;32(1):95-102. Review.PMID: 15726511 [PubMed - indexed for MEDLINE]Related articles

    43.

    Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group.

    Armanios M, Xu R, Forastiere AA, Haller DG, Kugler JW, Benson AB 3rd; Eastern Cooperative Oncology Group.

    J Clin Oncol. 2004 Nov 15;22(22):4495-9. Erratum in: J Clin Oncol. 2008 Aug 1;26(22):3819. PMID: 15542799 [PubMed - indexed for MEDLINE]Related articles

    44.

    Future directions with angiogenesis inhibitors in colorectal cancer.

    Bilenker JH, Haller DG.

    Clin Colorectal Cancer. 2004 Oct;4 Suppl 2:S86-93. Review.PMID: 15479485 [PubMed - indexed for MEDLINE]Related articles

    45.

    A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer.

    Martin NE, Brunner TB, Kiel KD, DeLaney TF, Regine WF, Mohiuddin M, Rosato EF, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, Tanaka WK, Morrison B, Deutsch P, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ, Hahn SM.

    Clin Cancer Res. 2004 Aug 15;10(16):5447-54.PMID: 15328183 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

    Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG.

    J Clin Oncol. 2004 Aug 15;22(16):3408-19. Epub 2004 Jun 15. Review.PMID: 15199089 [PubMed - indexed for MEDLINE]Related articles

    47.

    Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285).

    Pandya KJ, Lefkopoulou M, Petrelli NJ, Vaughn DJ, Smith TJ, Harris JE, Haller DG; Eastern Cooperative Oncology Group.

    Oncology. 2004;66(2):118-25.PMID: 15138363 [PubMed - indexed for MEDLINE]Related articles

    48.

    Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

    Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM.

    J Clin Oncol. 2004 May 15;22(10):1797-806. Epub 2004 Apr 5.PMID: 15067028 [PubMed - indexed for MEDLINE]Related articles

    49.

    Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.

    Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, MacDonald JS, Willett CG, Goldberg RM.

    J Clin Oncol. 2004 May 15;22(10):1785-96. Epub 2004 Apr 5.PMID: 15067027 [PubMed - indexed for MEDLINE]Related articles

    50.

    Physician-nurse collaboration in research in the 21st century.

    Houldin AD, Naylor MD, Haller DG.

    J Clin Oncol. 2004 Mar 1;22(5):774-6. No abstract available. PMID: 14990631 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...